Polymeric nanoparticles for RNA delivery

As exemplified by recent clinical approval of RNA drugs including the latest COVID-19 mRNA vaccines, RNA therapy has demonstrated great promise as an emerging medicine. Central to the success of RNA therapy is the delivery of RNA molecules into the right cells at the right location. While the clinic...

Full description

Saved in:
Bibliographic Details
Published inReference Module in Materials Science and Materials Engineering
Main Authors Jiang, Xingya, Abedi, Kimia, Shi, Jinjun
Format Book Chapter
LanguageEnglish
Published Elsevier Inc 01.01.2023
Subjects
Online AccessGet full text
ISBN9780128035818
0128035811
DOI10.1016/B978-0-12-822425-0.00017-8

Cover

More Information
Summary:As exemplified by recent clinical approval of RNA drugs including the latest COVID-19 mRNA vaccines, RNA therapy has demonstrated great promise as an emerging medicine. Central to the success of RNA therapy is the delivery of RNA molecules into the right cells at the right location. While the clinical success of nanotechnology in RNA therapy has been limited to lipid-based nanoparticles currently, polymers, due to their tunability and robustness, have also evolved as a class of promising material for the delivery of various therapeutics including RNAs. This article overviews different types of polymers used in RNA delivery and the methods for the formulation of polymeric nanoparticles and highlights recent progress of polymeric nanoparticle-based RNA therapy. [Display omitted]
ISBN:9780128035818
0128035811
DOI:10.1016/B978-0-12-822425-0.00017-8